Clinical trial
Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring…
NCT00315458 · Purdue Pharma LP, Industry · Terminated
Key facts
| NCT number | NCT00315458 |
|---|---|
| Title | Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension. |
| Official title | Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Determine Efficacy and Safety of Buprenorphine Transdermal System in Subjects With Moderate To Severe Osteoarthritis Pain Requiring Daily Treatment With Opioids |
| Lead sponsor | Purdue Pharma LP, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Buprenorphine transdermal patch, Placebo transdermal patch |
| Enrollment | 107 |
| Start date | Dec 1, 2003 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Apr 18, 2006 |
| Last update posted | Sep 3, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: